Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Takeda reports novel carbapenems

Nov. 24, 1997

New triazole antifungals from Pfizer

Nov. 24, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

AMBI cleared by FDA to commence nisin trials

Nov. 19, 1997

New antifungals from Pola

Nov. 19, 1997

Sankyo isolates A-76356, novel antibacterial agent

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

Inhibitors of viral neuraminidase from Biota

Nov. 17, 1997

Xoma reports phase II results of Neuprex in trauma patients

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...